Standard Biotools (LAB) Operating Expenses (2010 - 2026)

Standard Biotools (LAB) has reported Operating Expenses for 17 consecutive years, with $35.9 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Operating Expenses fell 1.11% year-over-year to $35.9 million in Q2 2026; TTM through Jun 2026 was $138.2 million, a 8.26% decrease from a year earlier, with the FY2025 full-year figure at $152.8 million, down 11.36% from the prior year.
• Operating Expenses was $35.9 million for Q2 2026 at Standard Biotools, up from $23.8 million in the prior quarter.
• Over five years, Operating Expenses peaked at $84.4 million in Q1 2024 and troughed at $23.8 million in Q1 2026.
• A 5-year average of $39.4 million and a median of $36.9 million in 2024 frame the typical range for Operating Expenses.
• Across the five-year window, Operating Expenses tumbled 74.25% in 2022 and soared 192.2% in 2024, its largest moves.
• Over 5 years, Operating Expenses stood at $32.3 million in 2022, then advanced by 7.63% to $34.7 million in 2023, then climbed by 7.76% to $37.4 million in 2024, then retreated by 3.77% to $36.0 million in 2025, then dropped by 0.29% to $35.9 million in 2026.
• The last three Operating Expenses figures came in at $35.9 million (Q2 2026), $23.8 million (Q1 2026), and $36.0 million (Q4 2025), per Business Quant data.